The Inhibitor Study

Over 2000+ Australian families are affected by the rare disorder known as TSC.
Tuberous Sclerosis Complex is a genetic disorder characterized by the growth of noncancerous tumours throughout the body. These benign tumours lead to significant health problems like triggering epileptic seizures.

This healthy volunteer study hopes to explore a medication with improved & fewer side-effects caused by currently available treatments.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!